Paper11547741
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.
Macdonald JS and 10 others. N Engl J Med, 2001. Cited by 2,705 papers, by iCite.
Cite this record
ConductScience Library. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. Papers, record 11547741. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11547741
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| Antimetabolites, Antineoplastic | Major topic |
| Esophagogastric Junction | Major topic |
| Fluorouracil | Major topic |
| Stomach Neoplasms | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Combined Modality Therapy | |
| Disease-Free Survival | |
| Female | |
| Gastrectomy | |
| Humans | |
| Leucovorin | |
| Lymph Node Excision | |
| Male | |
| Middle Aged | |
| Radiation Dosage | |
| Survival Rate |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA32102 | NCI NIH HHS | United States | R10CA032102 | PubMed and NIH | NIH RePORTER |
| CA35176 | NCI NIH HHS | United States | U10CA035176 | PubMed and NIH | NIH RePORTER |
| CA38926 | NCI NIH HHS | United States | U10CA038926 | PubMed and NIH | NIH RePORTER |
| U10CA032102 | NIH | NIH RePORTER |
Trials7
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT02078362 | ADCC Against Gastric Cancer Cells | Background | ClinicalTrials.gov | |
| NCT02640898 | Docetaxel-based Chemoradiotherapy Plus Periradiation Chemotherapy Compared With INT 0116 Adjuvant Arm in Gastric Cancer | Background | ClinicalTrials.gov | |
| NCT03515941 | Postoperative Chemoradiation or Chemotherapy After Preoperative Chemotherapy for Gastric Cancers | Background | ClinicalTrials.gov | |
| NCT03601988 | Phase III Trial of Adjuvant Chemo-radiotherapy After D2 Surgery of Gastric Cancer | Background | ClinicalTrials.gov | |
| NCT03680261 | Enriched-CRT 2017: Advanced Gastric Cancer With LN+ and LVI+, Chemotherapy vs. Chemoradiotherapy | Background | ClinicalTrials.gov | |
| NCT04808466 | Comparative Study of Lobaplatin and Paclitaxel in Advanced Gastric Cancer Patients With D2 Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy | Background | ClinicalTrials.gov | |
| NCT06784765 | Preventive Use of PIPAC in Locally Advanced Gastric Cancer. | Results | ClinicalTrials.gov |
Comments and corrections6
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 11796861 | Adjuvant chemoradiotherapy for gastric cancer. | https://conductscience.org/library/papers/11796861 | PubMed |
| Comment in | 11797725 | Adjuvant chemoradiotherapy for gastric cancer. | https://conductscience.org/library/papers/11797725 | PubMed |
| Comment in | 11797726 | Adjuvant chemoradiotherapy for gastric cancer. | https://conductscience.org/library/papers/11797726 | PubMed |
| Comment in | 12010873 | Does chemoradiotherapy after intended curative surgery increase survival of gastric cancer patients? | https://conductscience.org/library/papers/12010873 | PubMed |
| Comment in | 15218575 | Chemotherapy for pancreatic cancer. | https://conductscience.org/library/papers/15218575 | PubMed |
| Comment in | 17014037 | Treatment of gastric cancer. | https://conductscience.org/library/papers/17014037 | PubMed |
Cited by1,282
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,705 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42978552 | Comparative outcomes of adjuvant treatment approaches in resected stage I-III gastric cancer. | Front Oncol | 2026 | https://conductscience.org/library/papers/42978552 | PubMed |
| 42730213 | Chemoradiotherapy Is Associated With Improved Overall Survival in Intestinal-Type Gastric Cancer: A Retrospective Analysis. | World J Oncol | 2026 | https://conductscience.org/library/papers/42730213 | PubMed |
| 42719170 | Case Report: Two cases of pathologic complete response after upfront chemoimmunotherapy for initially unresectable gastric cancer. | Front Oncol | 2026 | https://conductscience.org/library/papers/42719170 | PubMed |
| 42512265 | Perioperative Nivolumab and Ipilimumab with Chemotherapy and Chemoradiation for Resectable Gastric and Gastroesophageal Junction Adenocarcinoma: A Phase 1/2 Non-Randomized Clinical Trial. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42512265 | PubMed |
| 42466102 | Impact of postoperative chemotherapy in patients resected for esophagogastric adenocarcinoma with major pathological response after preoperative chemotherapy: a study from the FREGAT database. | Ther Adv Med Oncol | 2026 | https://conductscience.org/library/papers/42466102 | PubMed |
| 42459646 | Decoding the PTM code of cGAS-STING in gastric cancer: from innate DNA sensing to precision combination therapy. | Front Immunol | 2026 | https://conductscience.org/library/papers/42459646 | PubMed |
| 42387114 | Multi-modal Prehabilitation and Outcomes after Gastroesophageal Cancer Surgery: A Cohort Study of Pulmonary Complications and Resilience to Major Postoperative Events. | Ann Surg Oncol | 2026 | https://conductscience.org/library/papers/42387114 | PubMed |
| 42352878 | The p53 Isoforms as Potential Biomarkers in Different Cancer Entities. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42352878 | PubMed |
| 42311712 | Emerging Role of Immunotherapy in Neoadjuvant, Adjuvant, and Perioperative Management of Gastric Cancer. | Cureus | 2026 | https://conductscience.org/library/papers/42311712 | PubMed |
| 42295761 | Adjuvant Chemoradiotherapy or Chemotherapy After D2 Gastrectomy in Gastric Cancer: A Randomized Clinical Trial. | JAMA Netw Open | 2026 | https://conductscience.org/library/papers/42295761 | PubMed |
| 42141340 | Biomarker-Driven Management of Nonmetastatic GEJ Adenocarcinoma. | Ann Surg Oncol | 2026 | https://conductscience.org/library/papers/42141340 | PubMed |
| 42141214 | Transforming perioperative treatment of gastro-oesophageal adenocarcinoma: triumphs, setbacks and future horizons. | Nat Rev Clin Oncol | 2026 | https://conductscience.org/library/papers/42141214 | PubMed |
| 42116136 | Adjuvant chemotherapy and lymph node examination interact to shape survival in older adults (≥ 75 years) with resected gastric cancer: a SEER-based propensity score-matched and competing-risk analysis. | World J Surg Oncol | 2026 | https://conductscience.org/library/papers/42116136 | PubMed |
| 41999560 | Survival Impact of Adjuvant Chemotherapy on Stage IB Gastric Cancer Patients After Radical Surgery. | J Gastrointest Cancer | 2026 | https://conductscience.org/library/papers/41999560 | PubMed |
| 41976296 | Robotic Gastrectomy and Delivery of Adjuvant Systemic Therapy in Locally Advanced Gastric Adenocarcinoma: An NCDB Propensity Score-Matched Analysis. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41976296 | PubMed |
| 41949664 | Machine learning nomograms for gastric cancer: addressing data limitations in SEER-based models. | Langenbecks Arch Surg | 2026 | https://conductscience.org/library/papers/41949664 | PubMed |
| 41938584 | A prognostic nomogram integrating preoperative IBI and MAR with clinicopathological factors for gastric cancer patients after radical gastrectomy. | Front Surg | 2026 | https://conductscience.org/library/papers/41938584 | PubMed |
| 41859180 | Perioperative chemotherapy (FLOT 4 + 4) versus total neoadjuvant therapy (TNT; FLOT ×8) for resectable gastric cancer: A systematic review and exploratory meta-analysis. | Surg Open Sci | 2026 | https://conductscience.org/library/papers/41859180 | PubMed |
| 41774292 | Clinicopathologic features and prognostic impact of late recurrence after gastrectomy for gastric cancer. | Gastric Cancer | 2026 | https://conductscience.org/library/papers/41774292 | PubMed |
| 41711159 | Cryptotanshinone alleviates DSS-induced colitis in mouse by regulating the balance of Treg/Th17 cells and M1 macrophage activation. | Eur J Histochem | 2026 | https://conductscience.org/library/papers/41711159 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11547741
GET https://conductscience.org/api/papers/v1/11547741/cited_by?page=2